Antimicrobial activity of a series of new 5-nitro-2-furaldehyde aminoacethydrazones.
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001412:Bacillus subtilis / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D002176:Candida albicans / Q000187:drug effects; D003013:Clostridium / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006835:Hydrazones / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009581:Nitrofurans / Q000494:pharmacology* / Q000627:therapeutic use; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D051381:Rats; D012475:Salmonella / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D014246:Trichomonas vaginalis / Q000187:drug effects; D014249:Trichophyton / Q000187:drug effects
D000081:Acetamides; D006835:Hydrazones; D009581:Nitrofurans